nach oben

Acta Neurologica Belgica

Erschienen in:

01.08.2018 | Original Article

Association of interleukin 6, interleukin 7 receptor alpha, and interleukin 12B gene polymorphisms with multiple sclerosis

verfasst von: Yvonne Benešová, Anna Vašků, Julie Bienertová-Vašků

Erschienen in: Acta Neurologica Belgica | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Pro-inflammatory and anti-inflammatory cytokines have been shown to play a crucial role in the pathophysiology of multiple sclerosis (MS). We investigated the association between interleukin (IL) IL6-174 G/C (rs1800795), IL7RA C/T (rs6897932), and IL-12B A1188C (rs3212227) gene polymorphisms (SNPs) and MS. The study consisted of 297 unrelated MS patients and 135 healthy individuals. In IL6-174G/C (rs1800795), a significant association between the C allele and MS risk [OR 1.41, 95% CI (1.05–1.92); P = 0.025] was found. Carriage of genotypes CC and CG were more common in MS patients [OR 1.58, 95% CI (1.04–2.39); P = 0.031] and also in female MS patients [OR 1.68, 95% CI (1.02–2.79); P = 0.043]. However, after applying Bonferroni’s correction the differences did not remain significant. No significant association between the IL7RA C/T (rs6897932) and IL12B A1188C (rs3212227) gene polymorphisms and MS susceptibility was observed. Regarding IL-12B A1188C (rs3212227), a significant association between the CC genotype and MS progression, expressed as MSSS, was demonstrated in the female MS group. Our results indicate that the distribution of IL6-174G/C (rs1800795) SNP was marginally associated with MS susceptibility. We also showed that IL-12B A1188C (rs3212227) can contribute to the progression of the disease in the Czech population.

Nur mit Berechtigung zugänglich

Hartung H, Bar-Or A, Zoukos Y (2004) What do we know about the mechanism of action of disease modifying treatments in MS? J Neurol 251:v12–v19CrossRefPubMed

Trapp BD, Nave KA (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Ann Rev Neurosci 31:247–269CrossRefPubMed

Hauser SL, Goodin DS (2012) Multiple sclerosis and other demyelinating diseases. In: Longo DL, Fauci SA, Kasper DL et al. (eds) Harrison’s principle of internal medicine, vol 18. McGraw-Hill, New York

McFarland HF, Martin R (2007) Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 8(9):913–919CrossRefPubMed

Sadovnick AD (2012) Genetic background of multiple sclerosis. Autoimmun Rev 11:163–166CrossRefPubMed

International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M et al (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476:214–219CrossRef

International Multiple Sclerosis Genetics Consortium (IMSGC), Wellcome Trust Case Control Consortium 2 (WTCCC2), International IBD Genetics Consortium (IIBDGC), Beecham AH et al (2013) Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 45:1353–1360CrossRef

Jadidi-Niaragh F, Mirshafiey A (2011) Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand J Immunol 74:1–13CrossRefPubMed

Pittock SJ, Lucchinetti CF (2007) The pathology of MS: new insights and potential clinical applications. Neurologist 13:45–56CrossRefPubMed

10.

Gaffen SL, Jain R, Garg AV, Cua DJ (2014) The IL-23–IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol 14:585–600CrossRefPubMedPubMedCentral

11.

Del Vecchio M, Bajetta E, Canova S et al (2007) Interleukin-12: biological properties and clinical application. Clin Cancer Res 13:4677–4685CrossRefPubMed

12.

Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3:133–146CrossRefPubMed

13.

Bank S, Andersen PS, Burisch J et al (2015) Polymorphisms in the toll-like receptor and the IL-23/IL-17 pathways were associated with susceptibility to inflammatory bowel disease in a Danish cohort. PLoS One 10(12):e0145302. https://doi.org/10.1371/journal.pone.0145302 CrossRefPubMedPubMedCentral

14.

Liu Z, Yadav PK, Xu X et al (2011) The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity. J Leukoc Biol 89:597–606CrossRefPubMed

15.

Zheng Y, Wang M, Tian T et al (2017) Role of interleukin-12 gene polymorphisms in the onset risk of cancer: a meta-analysis. Oncotarget 2:29795–29807

16.

Sun L, He C, Nair L et al (2015) Interleukin 12 (IL-12) family cytokines: role in immune pathogenesis and treatment of CNS autoimmune disease. Cytokine 75:249–255CrossRefPubMedPubMedCentral

17.

Tsunemi Y, Saeki H, Nakamura K et al (2002) Interleukin-12 p40 gene (IL12B) 3′-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J Dermatol Sci 30:161–166CrossRefPubMed

18.

Wang EY, Yang Q, Liao ZG (2015) Association of polymorphisms in interleukin (IL)-12A and -B genes with rheumatoid arthritis in a Chinese population. Clin Exp Immunol 180:83–89CrossRefPubMedPubMedCentral

19.

Shi X, Jia Y, Xie X et al (2017) Single-nucleotide polymorphisms of the IL-12 gene lead to a higher cancer risk: a meta-analysis based on 22,670 subjects. Genes Genet Syst. https://doi.org/10.1266/ggs.16-00024 PubMedCrossRef

20.

Gocket AR, Cravens PD, Ben LH et al (2007) T-bet regulaetes the fate of Th1 and Th17 lymphocytes in autoimmunity. J Immunol 178:1341–1348CrossRef

21.

Yang XO et al (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6:1133–1141CrossRefPubMedPubMedCentral

22.

Frausto RF et al (2009) Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis. J Immunol 183:2079–2088CrossRefPubMed

23.

Rivera-Chavez FA, Peters-Hybki DL, Barber RC, O’Keefe GE (2003) Interleukin-6 promoter haplotypes and interleukin-6 cytokine responses. Shock 20:218–223CrossRefPubMedPubMedCentral

24.

Slattery ML, Wolff RK, Curtin K et al (2009) Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways. Mutat Res 660:12–21CrossRefPubMed

25.

Tartter M, Hammen C, Bower JE et al (2015) Effects of chronic interpersonal stress exposure on depressive symptoms are moderated by genetic variation at IL6 and IL1β in youth. Brain Behav Immun 46:104–111CrossRefPubMedPubMedCentral

26.

Chumaeva N, Hintsanen M, Pulkki-Råback L et al (2014) Interleukin-6 gene polymorphism, chronic stress and atherosclerosis: interleukin-6-174G/C polymorphism, chronic stress and risk of early atherosclerosis in the Cardiovascular Risk in Young Finns study. Psychosom Res 76:333–338CrossRef

27.

Ururahy MA, de Souza KS, Oliveira YM et al (2015) Association of polymorphisms in IL6 gene promoter region with type 1 diabetes and increased albumin-to-creatinine ratio. Diabetes Metab Res Rev 31:500–506CrossRefPubMed

28.

Durães C, Moreira CS, Alvelos I et al (2014) Polymorphisms in the TNFA and IL6 genes represent risk factors for autoimmune thyroid disease. PloS One 9(8):e105492. https://doi.org/10.1371/journal.pone.0105492 CrossRefPubMedPubMedCentral

29.

Mirowska-Guzel D, Gromadzka G, Mach A et al (2011) Association of IL1A, IL1B, ILRN, IL6, IL10 and TNF-α polymorphisms with risk and clinical course of multiple sclerosis in a Polish population. J Neuroimmunol 236:87–92CrossRefPubMed

30.

Ye SK, Agata Y, Lee HC et al (2001) The IL-7 receptor controls the accessibility of the TCRgamma locus by Stat5 and histone acetylation. Immunity 15(5):813–823CrossRefPubMed

31.

Gregory SG, Schmidt S, Seth P, et al, Multiple Sclerosis Genetics Group (2007) Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 39:1083–1091CrossRefPubMed

32.

Liu H, Huang J, Dou M et al (2017) Variants in the IL7RA gene confer susceptibility to multiple sclerosis in Caucasians: evidence based on 9734 cases and 10436 controls. Sci Rep 26:1207CrossRef

33.

Tavakolpour S, Rahimzadeh G (2016) Interleukin 7 receptor polymorphisms and the risk of multiple sclerosis: a meta-analysis. Scand J Immunol 84:146–149CrossRefPubMed

34.

Akkad DA, Hoffjan S, Petrasch-Parwez E et al (2009) Variation in the IL7RA and IL2RA genes in German multiple sclerosis patients. J Autoimmun 32:110–115CrossRefPubMed

35.

Lundmark F, Duvefelt K, Iacobaeus E et al (2007) Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 39:1108–1113CrossRefPubMed

36.

Compston A, Coles A (2008) Multiple sclerosis. Lancet 25:372:1502–1517CrossRef

37.

Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302CrossRefPubMedPubMedCentral

38.

Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 33:1444–1452CrossRefPubMed

39.

Roxburgh RH, Seaman SR, Masterman T et al (2005) Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 64:1144–1151CrossRefPubMed

40.

International Multiple Sclerosis Genetics Consortium, Hafler DA et al (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357:851–862CrossRef

41.

Nicot A (2009) Gender and sex hormones in multiple sclerosis pathology and therapy. Front Biosci 14:4477–4515CrossRef

42.

Kikuchi S, Fukazawa T, Niino M et al (2002) Estrogen receptor gene polymorphism and multiple sclerosis in Japanese patients: interaction with HLA-DRB1*1501 and disease modulation. J Neuroimmunol 128(1–2):77–81CrossRefPubMed

43.

Benešová Y, Vašků A, Štourač P et al (2013) Association of HLA-DRB1*1501 tagging rs3135388 gene polymorphism with multiple sclerosis. J Neuroimmunol 255(1–2):92–96CrossRefPubMed

44.

Čierny D, Hányšová S, Michalik J et al (2015) Genetic variants in interleukin 7 receptor α chain (IL-7Rα) are associated with multiple sclerosis risk and disability progression in Central European Slovak population. J Neuroimmunol 282:80–84CrossRefPubMed

45.

Weber F, Fontaine B, Cournu-Rebeix I et al (2008) IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Genes Immun 9:259–263CrossRefPubMed

46.

Zhang Z, Duvefelt K, Svensson F et al (2005) Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis. Genes Immun 6:145–152CrossRefPubMed

47.

Traggiai E, Biagioli T, Rosati E et al (2001) IL-7 enhanced T-cell response to myelin proteins in multiple sclerosis. J Neuroimmunol 121:111–119CrossRefPubMed

48.

Jäger J, Schulze C, Rösner S, Martin R (2013) IL7RA haplotype-associated alterations in cellular immune function and gene expression patterns in multiple sclerosis. Genes Immun 14:453–461CrossRefPubMed

49.

Traboulsee AL, Bernales CQ, Ross JP et al (2014) Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression. Neurogenetics 15:165–169CrossRefPubMedPubMedCentral

50.

Zuvich RL, McCauley JL, Oksenberg JR, International Multiple Sclerosis Genetics Consortium, Aubin C, Cross AH, Piccio L et al (2010) Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility. Hum Genet 127:525–535CrossRefPubMedPubMedCentral

51.

Mihailova S, Ivanova M, Mihaylova A et al (2005) Pro- and anti-infalmmatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients. J Neuroimmunol 168:138–143CrossRefPubMed

52.

Shahbazi M, Ebadi H, Fathi D et al (2010) HLA-DRB1*1501 intensifies the impact of IL-6 promoter polymorphism on the susceptibility to multiple sclerosis in an Iranian population. Mult Scler 16:1173–1176CrossRefPubMed

53.

Ewald L, Beate LW, Stephanie S et al (2015) Analysis of a functional IL-6 gene polymorphism in HLAB27 associated and intermediate uveitis gives new insight in disease pathogenesis and commonality with other autoimmune diseases. J Immunol Res. https://doi.org/10.1155/2015/174062 PubMedPubMedCentralCrossRef

54.

Schönrock LM, Gawlowski G, Brück W (2000) Interleukin-6 expression in human multiple sclerosis lesions. Neurosci Lett 10:45–48CrossRef

55.

Schulte-Herbrüggen O, Nassenstein C, Lommatzsch M et al (2005) Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes. J Neuroimmunol 160:204–209CrossRefPubMed

56.

Kimura A, Kishimoto T (2010) IL-6: regulator of Treg/Th17 balance. Eur J Immunol 40:1830–1835CrossRefPubMed

57.

Huang J, Yang Y, Zhou F et al (2016) Meta-analysis of the IL23R and IL12B polymorphisms in multiple sclerosis. Int J Neurosci 126:205–212CrossRefPubMed

58.

Javan MR, Shahraki S, Safa A et al (2017) An interleukin 12 B single nucleotide polymorphism increases IL-12p40 production and is associated with increased disease susceptibility in patients with relapsing–remitting multiple sclerosis. Neurol Res 39:4 35–441CrossRef

59.

Liu M, Hu X, Wang Y et al (2014) Association of IL-23 and its receptor gene single-nucleotide polymorphisms with multiple sclerosis in Chinese southern population. Int J Neurosci 124:904–907CrossRefPubMed

60.

Cordell HJ, Clayton DG (2005) Genetic association studies. Lancet 366:1121–1131CrossRefPubMed

Titel: Association of interleukin 6, interleukin 7 receptor alpha, and interleukin 12B gene polymorphisms with multiple sclerosis
verfasst von: Yvonne Benešová
Anna Vašků
Julie Bienertová-Vašků
Publikationsdatum: 01.08.2018
Verlag: Springer International Publishing
Erschienen in: Acta Neurologica Belgica / Ausgabe 3/2018
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI: https://doi.org/10.1007/s13760-018-0994-9

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Association of interleukin 6, interleukin 7 receptor alpha, and interleukin 12B gene polymorphisms with multiple sclerosis

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Prefoveal floaters as a differential diagnosis to optic neuritis: ‘‘mouches dormantes’’

Antibody profile may predict outcome in ocular myasthenia gravis

Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy

The course of epilepsy and seizure control in pregnant women

Sensory neuropathic symptoms in idiopathic Parkinson’s disease: prevalence and impact on quality of life

Microstructural changes in patients with Parkinson disease and REM sleep behavior disorder: depressive symptoms versus non-depressed

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie